We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,545 results
  1. Microfluidic Capture Device for Simple, Cell Surface Marker-Based Quantification of Senescent CD8+ T Cells

    Among human CD8 + T cells, senescent cells are marked by the expression of CD57. The frequency of senescent CD57 + CD8 + T cells is significantly...

    Yo-han Choi, Woo-Joong Kim, ... Wonhee Lee in BioChip Journal
    Article Open access 08 March 2024
  2. Relationship Between CD8+ T Cells and Prognosis of Esophageal Cancer Patients: A Systematic Review and Meta-analysis

    Tumor infiltrating lymphocytes (TILs), especially CD8+ T cells, play an important role in the process of anti-tumor immune response and are...

    Ben Liu, Zeyuan Liu, Chao Gao in Molecular Biotechnology
    Article 15 April 2023
  3. Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4+CD8+T cells expansion

    Abstract

    Plant-derived exosome-like nanoparticles (PDENs) have been paid great attention in the treatment of ulcerative colitis (UC). As a proof of...

    Min-zheng Zhu, Hao-ming Xu, ... De-feng Li in Journal of Nanobiotechnology
    Article Open access 31 August 2023
  4. Long-lasting postoperative analgesia with local anesthetic-loaded hydrogels prevent tumor recurrence via enhancing CD8+T cell infiltration

    Postoperative pain (POP) can promote tumor recurrence and reduce the cancer patient's quality of life. However, POP management has always been...

    Mingxu Zhao, Shasha Zhu, ... Jiqian Zhang in Journal of Nanobiotechnology
    Article Open access 10 February 2023
  5. CD16 CAR-T cells enhance antitumor activity of CpG ODN-loaded nanoparticle-adjuvanted tumor antigen-derived vaccinevia ADCC approach

    Background

    Combinatorial immunotherapy strategies for enhancing the responsiveness of immune system have shown great promise for cancer therapy....

    **aofei Zhang, Qin Hu, ... **aodong D. Han in Journal of Nanobiotechnology
    Article Open access 20 May 2023
  6. Microfluidics-enabled fluorinated assembly of EGCG-ligands-siTOX nanoparticles for synergetic tumor cells and exhausted t cells regulation in cancer immunotherapy

    Immune checkpoint inhibitor (ICI)-derived evolution offers a versatile means of develo** novel immunotherapies that targets programmed death-ligand...

    **aowei Han, Guozheng Zhang, ... Pengkai Wu in Journal of Nanobiotechnology
    Article Open access 04 March 2024
  7. Synergetic regulation of cancer cells and exhausted T cells to fight cold tumors with a fluorinated EGCG-based nanocomplex

    Immune therapy that targets PD-L1 (programmed cell death-ligand 1) is attractive to augment immune response by breaking the programmed cell death-1...

    **lin Zhang, Mingyue Wang, ... Kaikai Wang in Journal of Nanobiotechnology
    Article Open access 14 November 2023
  8. Dual-binding nanoparticles improve the killing effect of T cells on solid tumor

    Adoptive cell therapy (ACT) was one of the most promising anti-tumor modalities that has been confirmed to be especially effective in treating...

    Zhenyu Luo, Lihua Luo, ... Jian You in Journal of Nanobiotechnology
    Article Open access 07 June 2022
  9. ImmunoPET imaging of human CD8+ T cells with novel 68Ga-labeled nanobody companion diagnostic agents

    Background

    Although immunotherapy has revolutionized treatment strategies for some types of cancers, most patients failed to respond or obtain...

    Haitao Zhao, Chao Wang, ... Jianjun Liu in Journal of Nanobiotechnology
    Article Open access 09 February 2021
  10. Nano-Particulate Platforms for Vaccine Delivery to Enhance Antigen-Specific CD8+ T-Cell Response

    Vaccines remain the most effective way to protect populations against deathly infectious diseases. Several disadvantages associated with the...
    Jhanvi Sharma, Carcia S. Carson, ... Sebastian Joyce in Vaccine Design
    Protocol 2022
  11. A Method to Evaluate In Vivo CD8+ T Cell Cytotoxicity in a Murine Model

    Herein, a method to measure in vivo CD8+ T cell cytotoxicity in a murine model is presented. The activation of a strong CD8+ T cell response is...
    Felicity C. Stark, Renu Dudani, ... Michael J. McCluskie in Vaccine Delivery Technology
    Protocol 2021
  12. BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma

    Background

    BCMA-directed autologous chimeric antigen receptor T (CAR-T) cells have shown excellent clinical efficacy in relapsed or refractory...

    Qizhong Lu, Hexian Li, ... Ai** Tong in Journal of Nanobiotechnology
    Article Open access 23 May 2024
  13. Tumor cell membrane remodeling with universal ligand for CAR-T cells to inhibit solid tumors

    Heterogeneity is a major obstacle to the success of CAR-T therapy in treating solid tumors. The complex tumor microenvironment and varying phenotypes...

    **-Xuan Fan, Zhong-Bao Hu, ... **an-Zheng Zhang in Science China Chemistry
    Article 17 October 2023
  14. T Lymphocyte Characteristic Changes Under Serum Cytokine Deviations and Prognostic Factors of COVID-19 in Pregnant Women

    Physiological changes during pregnancy make the individuals more susceptible to severe respiratory diseases. Hence, pregnant women with coronavirus...

    Ehsan Aminsobahni, Maryam Hosseini, ... Mehdi Yousefi in Applied Biochemistry and Biotechnology
    Article 10 November 2023
  15. LMP2-mRNA lipid nanoparticle sensitizes EBV-related tumors to anti-PD-1 therapy by reversing T cell exhaustion

    Background

    Targeting EBV-proteins with mRNA vaccines is a promising way to treat EBV-related tumors like nasopharyngeal carcinoma (NPC). We assume...

    Yu **ang, Miaomiao Tian, ... Xuelei Ma in Journal of Nanobiotechnology
    Article Open access 08 September 2023
  16. A novel “prime and pull” strategy mediated by the combination of two dendritic cell-targeting designs induced protective lung tissue-resident memory T cells against H1N1 influenza virus challenge

    Vaccination is still the most promising strategy for combating influenza virus pandemics. However, the highly variable characteristics of influenza...

    Zhannan Wang, Yingkai He, ... Chunfeng Wang in Journal of Nanobiotechnology
    Article Open access 13 December 2023
  17. TLR agonist rMBP-NAP inhibits B16 melanoma tumor growth via induction of DCs maturation and T-cells cytotoxic response

    Melanoma is the most aggressive skin cancer with increasing incidence and poor prognosis all over the world. Recent research has found that...

    Jiaojiao Liu, Cong Ding, ... Qiaozhen Kang in Cytotechnology
    Article 02 July 2022
  18. Th9 Cytokines Inhibit Proliferation, Promote Apoptosis, and Immune Escape in Thyroid Carcinoma Cells

    To investigate the regulatory effects of T helper 9 (Th9) cytokines on the proliferation, apoptosis and immune escape of thyroid cancer cells. The...

    **nyu Ying, **nyi Ma, ... Bo Zhou in Applied Biochemistry and Biotechnology
    Article 15 January 2024
  19. Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy

    Despite the advent of numerous targeted therapies in clinical practice, anthracyclines, including doxorubicin (DOX), continue to play a pivotal role...

    Marta Sevieri, Francesco Andreata, ... Serena Mazzucchelli in Journal of Nanobiotechnology
    Article Open access 15 April 2024
  20. Engineering CAR-T cells to activate small-molecule drugs in situ

    Chimeric antigen receptor (CAR)-T cells represent a major breakthrough in cancer therapy, wherein a patient’s own T cells are engineered to recognize...

    Thomas J. Gardner, J. Peter Lee, ... David A. Scheinberg in Nature Chemical Biology
    Article 30 December 2021
Did you find what you were looking for? Share feedback.